Zap and delay: radiation may buy time for cancer patients

NCT ID NCT02756793

Ongoing Disease control Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving precise, high-dose radiation to a small number of growing cancer spots can help people with metastatic non-small cell lung cancer stay stable longer. About 90 adults whose cancer has started to grow in just a few places while on standard treatment will either continue their usual care or also receive radiation to those spots. The goal is to see if this approach delays the next overall cancer progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm Neoplasm Metastasis non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC CANCER

Contacts and locations

Locations

Alberta Health Services-Cross Cancer Institute

Edmonton, Alberta, T6G 1Z2, Canada
BC Cancer - Prince George

Prince George, British Columbia, V2M 7E9, Canada
BC Cancer - Victoria Centre

Victoria, British Columbia, V8R 4X1, Canada
BC Cancer Agency Branch

Vancouver, British Columbia, V5Z 4E6, Canada
BC Cancer Fraser Valley Centre

Surrey, British Columbia, V3V 1Z2, Canada
London Regional Cancer Program

London, Ontario, N6A 4L6, Canada
Princess Margaret Cancer Centre

Toronto, Ontario, M5G1X6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.